Rexulti 0.5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FZGC8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,929
Award facts
- Contract value 100% obligated
- $2,928.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count) with a contract ceiling value of $2,928.69. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025, issued on July 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering numerous therapeutic domains, including neurological, endocrine, pain management, and infectious disease medications. As the prime contractor on this delivery order, AmerisourceBergen leverages its established relationships with the Defense Health Agency and other government healthcare systems to fulfill medical supply needs. The competitive, non-set-aside nature of this award and the firm fixed pricing structure reflect the company's demonstrated capability to meet federal procurement requirements efficiently and cost-effectively within open competition.
Quick answers
Who was awarded contract SPE2DB25FZGC8?
SPE2DB25FZGC8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FZGC8 worth?
The government has obligated $2,929 on SPE2DB25FZGC8.
Is contract SPE2DB25FZGC8 an order under another contract?
Yes. SPE2DB25FZGC8 is a delivery order under SPE2DB24D1107, an indefinite delivery contract.
Was contract SPE2DB25FZGC8 competed?
The extent of competition for SPE2DB25FZGC8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award